SCHEMBL18044686

SCHEMBL18044686

CC(C)(O)Cn1cc(-c2ccc(NC(=O)c3cc4c(n(-c5ccc(F)cc5)c3=O)CCCC4=O)cc2)c2c(N)ncnc21

nearest known ligand 0.62

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 12/20 0.62
▸ MERTK Q12866 6/20 0.62
▸ TYRO3 Q06418 4/20 0.49
▸ MET P08581 10/20 0.48
▸ TP53 P04637 1/20 0.47
▸ MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16709400 0.93 MERTK (0.53) AXLMERTKTYRO3METTP53
SCHEMBL18044532 0.92 AXL (0.53) AXLMERTKTYRO3METTP53
SCHEMBL18044634 0.92 AXL (0.52) AXLMERTKTYRO3METTP53
SCHEMBL18044526 0.89 TYRO3 (0.48) AXLMERTKTYRO3METMAPT
SCHEMBL18044549 0.88 AXL (0.66) AXLMERTKTYRO3METTP53
SCHEMBL18044745 0.87 AXL (0.47) AXLMERTKTYRO3MET
SCHEMBL18044682 0.87 MERTK (0.49) AXLMERTKTYRO3METTP53
SCHEMBL18044555 0.86 NEK7 (0.51) AXLMERTKTYRO3METMAPT
SCHEMBL18045186 0.86 AXL (0.45) AXLMERTKMET
SCHEMBL18044581 0.85 ALDH1A1 (0.57) AXLMERTKTYRO3TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3067356-B1 PYRROLO PYRIMIDINE DERIVATIVE ONO PHARMACEUTICAL CO (JP) 2018-07-04 — — EP disclosed
US-9586967-B2 Pyrrolo pyrimidine derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2017-03-07 — — US disclosed
US-20160264579-A1 PYRROLO PYRIMIDINE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2016-09-15 — — US disclosed
EP-3067356-A1 PYRROLO PYRIMIDINE DERIVATIVE ONO Pharmaceutical Co., Ltd. (JP) 2016-09-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160264579-A1 PYRROLO PYRIMIDINE DERIVATIVE AXL, FLT3, TYRO3 AXL 1/4885MERTK 5/4885TYRO3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback